Alantolactone selectively suppresses STAT3 activation and exhibits potent anticancer activity in MDA-MB-231 cells

Jaemoo Chun(Korea Institute of Oriental Medicine), Yeong Shik Kim(Seoul National University), Rui-Juan Li(Shenyang Pharmaceutical University), Maosheng Cheng(Shenyang Pharmaceutical University)
Cancer Letters
November 29, 2014
Cited by 129


Related Papers